世界のカルバマゼピン市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Carbamazepine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:88
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、カルバマゼピンの世界市場を広く調査・分析し、今後の市場展望をまとめております。カルバマゼピンの種類別市場規模(カプセル、錠剤)、用途別市場規模(発作、神経痛、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Novartis、Apotex Corporation、Teva、Biomed Pharma、Nucare Pharmaceuticals、Taro Pharmaceuticals
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:カプセル、錠剤
・用途別分析2016年-2026年:発作、神経痛、その他
・カルバマゼピンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・カルバマゼピンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・カルバマゼピンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・カルバマゼピンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・カルバマゼピンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Carbamazepine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Carbamazepine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Carbamazepine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Carbamazepine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Capsule
Tablet

Market segment by Application can be divided into
Seizures
Nerve Pain
Others

The key market players for global Carbamazepine market are listed below:
Novartis
Apotex Corporation
Teva
Biomed Pharma
Nucare Pharmaceuticals
Taro Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Carbamazepine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbamazepine, with price, sales, revenue and global market share of Carbamazepine from 2019 to 2021.
Chapter 3, the Carbamazepine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbamazepine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Carbamazepine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Carbamazepine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Carbamazepine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carbamazepine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Carbamazepine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Seizures
1.3.3 Nerve Pain
1.3.4 Others
1.4 Global Carbamazepine Market Size & Forecast
1.4.1 Global Carbamazepine Sales in Value (2016-2026))
1.4.2 Global Carbamazepine Sales in Volume (2016-2026)
1.4.3 Global Carbamazepine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Carbamazepine Production Capacity Analysis
1.5.1 Global Carbamazepine Total Production Capacity (2016-2026)
1.5.2 Global Carbamazepine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carbamazepine Market Drivers
1.6.2 Carbamazepine Market Restraints
1.6.3 Carbamazepine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Carbamazepine Product and Services
2.1.4 Novartis Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Apotex Corporation
2.2.1 Apotex Corporation Details
2.2.2 Apotex Corporation Major Business
2.2.3 Apotex Corporation Carbamazepine Product and Services
2.2.4 Apotex Corporation Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Carbamazepine Product and Services
2.3.4 Teva Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Biomed Pharma
2.4.1 Biomed Pharma Details
2.4.2 Biomed Pharma Major Business
2.4.3 Biomed Pharma Carbamazepine Product and Services
2.4.4 Biomed Pharma Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Nucare Pharmaceuticals
2.5.1 Nucare Pharmaceuticals Details
2.5.2 Nucare Pharmaceuticals Major Business
2.5.3 Nucare Pharmaceuticals Carbamazepine Product and Services
2.5.4 Nucare Pharmaceuticals Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Carbamazepine Product and Services
2.6.4 Taro Pharmaceuticals Carbamazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Carbamazepine Sales by Manufacturer
3.1 Global Carbamazepine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Carbamazepine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Carbamazepine
3.4 Market Concentration Rate
3.4.1 Top 3 Carbamazepine Manufacturer Market Share
3.4.2 Top 6 Carbamazepine Manufacturer Market Share
3.5 Global Carbamazepine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Carbamazepine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carbamazepine Market Size by Region
4.1.1 Global Carbamazepine Sales in Volume by Region (2016-2026)
4.1.2 Global Carbamazepine Revenue by Region (2016-2026)
4.2 North America Carbamazepine Revenue (2016-2026)
4.3 Europe Carbamazepine Revenue (2016-2026)
4.4 Asia-Pacific Carbamazepine Revenue (2016-2026)
4.5 South America Carbamazepine Revenue (2016-2026)
4.6 Middle East and Africa Carbamazepine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Carbamazepine Sales in Volume by Type (2016-2026)
5.2 Global Carbamazepine Revenue by Type (2016-2026)
5.3 Global Carbamazepine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Carbamazepine Sales in Volume by Application (2016-2026)
6.2 Global Carbamazepine Revenue by Application (2016-2026)
6.3 Global Carbamazepine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Carbamazepine Sales by Type (2016-2026)
7.2 North America Carbamazepine Sales by Application (2016-2026)
7.3 North America Carbamazepine Market Size by Country
7.3.1 North America Carbamazepine Sales in Volume by Country (2016-2026)
7.3.2 North America Carbamazepine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Carbamazepine Sales by Type (2016-2026)
8.2 Europe Carbamazepine Sales by Application (2016-2026)
8.3 Europe Carbamazepine Market Size by Country
8.3.1 Europe Carbamazepine Sales in Volume by Country (2016-2026)
8.3.2 Europe Carbamazepine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Carbamazepine Sales by Type (2016-2026)
9.2 Asia-Pacific Carbamazepine Sales by Application (2016-2026)
9.3 Asia-Pacific Carbamazepine Market Size by Region
9.3.1 Asia-Pacific Carbamazepine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Carbamazepine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Carbamazepine Sales by Type (2016-2026)
10.2 South America Carbamazepine Sales by Application (2016-2026)
10.3 South America Carbamazepine Market Size by Country
10.3.1 South America Carbamazepine Sales in Volume by Country (2016-2026)
10.3.2 South America Carbamazepine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carbamazepine Sales by Type (2016-2026)
11.2 Middle East & Africa Carbamazepine Sales by Application (2016-2026)
11.3 Middle East & Africa Carbamazepine Market Size by Country
11.3.1 Middle East & Africa Carbamazepine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Carbamazepine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Carbamazepine Typical Distributors
12.3 Carbamazepine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Novartis、Apotex Corporation、Teva、Biomed Pharma、Nucare Pharmaceuticals、Taro Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のカルバマゼピン市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Carbamazepine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。